Blackstone Loan Share Price (BGLF)

Scandiexpat; also, do you have a view here? On the wind down.

The lack of 'action' supports my view that it will take quite a while (3 years), and frankly I'm quite happy with that, both in that it's likely to provide the same level.of income for some time, and that they aren't firesaling their positions but maxamising into natural rundown, an elongation that will see much of the NAV discount narrow and materialise, yes, in to lower yield, but returns of capital. As a patient investor, I've actually wondered whether adding here, as I do think most of that NAV discount is real.

Hi Scandiexpat; you really are a globetrotter.....from UK, in Scandinavia, with a Swiss broker! Are the deeds of your house held through a nominee shell company in the Cayman Islands?

Jokes aside, hope you/your investments are well.

Forget, got it one day late....

Anybody else who didn't get paid out yesterday? It could be my Swiss Asset Manager not being fully integrated in EUR system...

Kentio; thanks your kind words. I am far from a specialist on these types of stocks, I just took a LOT of time before I first invested here/ in tiss type of stock.

BGLF was actually the first stock I bought when I started running my own pension pot, along with a few other CLO/debt stocks. Whilst taking a long term view, and adventurous, I was at start, and remain today, disproportionally overweight as a 'sector', and within individual stocks. I have never sold these types, having used the yields to diversify, to the point, over time, through their continual success, that most have 'naturally' reduced to around the recommended maximum of 5% per stock. BGLF, this arena has been good to me, and my only regret, is that I tempered my adventurousness, and erred towards the 'balanced' portfolio so extolled by experts. Frankly If I'd just gone 100% CLO type stocks, I'd be laughing my socks off now. That said, I do inherently believe in a spread, of risk and reward, and BGLF, supposedly so risky has been only rewarding for me. I'm going to hold to end, as I do think much of the current NAV discount will be realised for the patient.

As for your question on VTA - I revisited their lasted news/announcements on seeing your question. It's just my view, but the lower comparative yield isn't an issue, isn't a flag that they are inferior/struggling. Far from it. To me VTA are more conservatively run, and look to pay a constantish yield rather than one that pays (up or down) the success in any given period. On the one hand smoothing the yield against fluctuating income, whilst retaining cash for oppurtunity that may appear.

Other than BGLF (through Blackstone), I know of no other CLO type that has greater access to resources that VTA has (through AXA), and in that, I find it a slower surer bedrock of a stock.